Zhongfu Technology: Plans to acquire 87% equity of Junke Zhengyuan for a consideration of 1 billion yuan

Mars Finance News: Zhongfu Technology, a company listed on the Growth Enterprise Market, announced plans to acquire 87% of the equity in the national-level specialized and innovative small giant enterprise Junke Zhengyuan for 1 billion yuan, officially securing a leading CRO platform in China’s biological sample analysis field. After this integration, Zhongfu Yuanchuang will quickly build an integrated “preclinical + clinical” service capability, providing innovative drug companies with end-to-end, full-chain, data-unified one-stop solutions.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin